Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Michael R. Jaff, D.O.

Co-Author

This page shows the publications co-authored by Michael Jaff and Ido Weinberg.
Connection Strength

12.526
  1. Response by Weinberg et al to Letter Regarding Article, "Carotid Stent Fractures Are Not Associated With Adverse Events: Results From the ACT-1 Multicenter Randomized Trial (Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease)". Circulation. 2018 06 12; 137(24):2676-2677.
    View in: PubMed
    Score: 0.785
  2. Carotid Stent Fractures Are Not Associated With Adverse Events: Results From the ACT-1 Multicenter Randomized Trial (Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease). Circulation. 2018 01 02; 137(1):49-56.
    View in: PubMed
    Score: 0.749
  3. How to Treat Critical Limb Ischemia: The Critical Need for High-Grade Evidence. JACC Cardiovasc Interv. 2016 12 26; 9(24):2566-2567.
    View in: PubMed
    Score: 0.710
  4. Can Inferior Vena Cava Filters Change Their Struts? JACC Cardiovasc Interv. 2016 12 12; 9(23):2449-2451.
    View in: PubMed
    Score: 0.704
  5. Anti-platelet and anti-hypertension medication use in patients with fibromuscular dysplasia: Results from the United States Registry for Fibromuscular Dysplasia. Vasc Med. 2015 Oct; 20(5):447-53.
    View in: PubMed
    Score: 0.634
  6. Accelerated thrombolysis for pulmonary embolism: will clinical benefit be ULTIMAtely realized? Circulation. 2014 Jan 28; 129(4):420-1.
    View in: PubMed
    Score: 0.572
  7. Blood pressure response to renal artery stenting in 901 patients from five prospective multicenter FDA-approved trials. Catheter Cardiovasc Interv. 2014 Mar 01; 83(4):603-9.
    View in: PubMed
    Score: 0.571
  8. Effect of delayed inferior vena cava filter retrieval after early initiation of anticoagulation. Am J Cardiol. 2014 Jan 15; 113(2):389-94.
    View in: PubMed
    Score: 0.568
  9. Inferior vena cava filters: truth or dare? Circ Cardiovasc Interv. 2013 Oct 01; 6(5):498-500.
    View in: PubMed
    Score: 0.567
  10. Treating large pulmonary emboli: do the guidelines guide us? Curr Opin Pulm Med. 2013 Sep; 19(5):413-21.
    View in: PubMed
    Score: 0.564
  11. Inferior vena cava filters. JACC Cardiovasc Interv. 2013 Jun; 6(6):539-47.
    View in: PubMed
    Score: 0.554
  12. Anatomic correlates of supra-normal ankle brachial indices. Catheter Cardiovasc Interv. 2013 May; 81(6):1025-30.
    View in: PubMed
    Score: 0.543
  13. Nonatherosclerotic arterial disorders of the lower extremities. Circulation. 2012 Jul 10; 126(2):213-22.
    View in: PubMed
    Score: 0.521
  14. Spontaneous blue finger syndrome: a benign process. Am J Med. 2012 Jan; 125(1):e1-2.
    View in: PubMed
    Score: 0.502
  15. Images in vascular medicine. Penile ischemic lesions associated with anti-phospholipid antibody syndrome. Vasc Med. 2012 Feb; 17(1):68-9.
    View in: PubMed
    Score: 0.496
  16. Response to Gwozdz and colleagues. Vasc Med. 2020 02; 25(1):90-91.
    View in: PubMed
    Score: 0.216
  17. Relationships between the use of pharmacomechanical catheter-directed thrombolysis, sonographic findings, and clinical outcomes in patients with acute proximal DVT: Results from the ATTRACT Multicenter Randomized Trial. Vasc Med. 2019 10; 24(5):442-451.
    View in: PubMed
    Score: 0.212
  18. Usefulness of a Computerized Reminder System to Improve Inferior Vena Cava Filter Retrieval and Complications. Am J Cardiol. 2019 01 15; 123(2):348-353.
    View in: PubMed
    Score: 0.201
  19. Peripheral vascular manifestation in patients receiving an amphetamine analog: A case series. Vasc Med. 2019 Feb; 24(1):50-55.
    View in: PubMed
    Score: 0.199
  20. Contemporary Management and Outcomes of Patients with Massive and Submassive Pulmonary Embolism. Am J Med. 2018 12; 131(12):1506-1514.e0.
    View in: PubMed
    Score: 0.199
  21. Extra-corporeal membrane oxygenation and outcomes in massive pulmonary embolism: Two eras at an urban tertiary care hospital. Vasc Med. 2018 02; 23(1):60-64.
    View in: PubMed
    Score: 0.189
  22. Presentation, treatment, and outcomes in patients with spontaneous isolated celiac and superior mesenteric artery dissection. Vasc Med. 2017 12; 22(6):505-511.
    View in: PubMed
    Score: 0.186
  23. Impact of Pulmonary Arterial Clot Location on Pulmonary Embolism Treatment and Outcomes (90 Days). Am J Cardiol. 2017 03 01; 119(5):802-807.
    View in: PubMed
    Score: 0.177
  24. Comparison of Inferior Vena Cava Filters Placed at the Bedside via Intravenous Ultrasound Guidance Versus Fluoroscopic Guidance. Ann Vasc Surg. 2017 Feb; 39:250-255.
    View in: PubMed
    Score: 0.173
  25. Anticoagulation Is Associated with Decreased Inferior Vena Cava Filter-Related Complications in Patients with Metastatic Carcinoma. Am J Med. 2017 Jan; 130(1):77-82.e1.
    View in: PubMed
    Score: 0.172
  26. Popliteal venous aneurysms: characteristics, management strategies, and clinical outcomes--a modern single-center series. Ann Vasc Surg. 2014 Nov; 28(8):1816-22.
    View in: PubMed
    Score: 0.150
  27. Inferior vena cava filter usage, complications, and retrieval rate in cancer patients. Am J Med. 2014 Nov; 127(11):1111-1117.
    View in: PubMed
    Score: 0.149
  28. Inferior vena cava compression by a hematoma. Vasc Med. 2014 Apr; 19(2):146-147.
    View in: PubMed
    Score: 0.146
  29. The systolic blood pressure difference between arms and cardiovascular disease in the Framingham Heart Study. Am J Med. 2014 Mar; 127(3):209-15.
    View in: PubMed
    Score: 0.143
  30. Comprehensive medical management of peripheral arterial disease. Prog Cardiovasc Dis. 2011 Jul-Aug; 54(1):2-13.
    View in: PubMed
    Score: 0.121
  31. Analysis of Costs and Payments for Inferior Vena Cava Filter Retrieval in the Medicare Population. J Vasc Interv Radiol. 2021 Aug; 32(8):1164-1169.
    View in: PubMed
    Score: 0.061
  32. Time-Restricted Salutary Effects of Blood Flow Restoration on Venous Thrombosis and Vein Wall Injury in Mouse and Human Subjects. Circulation. 2021 Mar 23; 143(12):1224-1238.
    View in: PubMed
    Score: 0.059
  33. Outcomes of catheter-directed versus systemic thrombolysis for the treatment of pulmonary embolism: A real-world analysis of national administrative claims. Vasc Med. 2020 08; 25(4):334-340.
    View in: PubMed
    Score: 0.056
  34. Ultrasound-Accelerated Thrombolysis and Venoplasty for the Treatment of the Postthrombotic Syndrome: Results of the ACCESS PTS Study. J Am Heart Assoc. 2020 02 04; 9(3):e013398.
    View in: PubMed
    Score: 0.055
  35. Association of Survival With Femoropopliteal Artery Revascularization With Drug-Coated Devices. JAMA Cardiol. 2019 04 01; 4(4):332-340.
    View in: PubMed
    Score: 0.052
  36. Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute pulmonary embolism: A multicenter comparison of patient-centered outcomes. Vasc Med. 2019 06; 24(3):241-247.
    View in: PubMed
    Score: 0.052
  37. Drug-Eluting Stent Implantation and Long-Term Survival Following Peripheral Artery Revascularization. J Am Coll Cardiol. 2019 05 28; 73(20):2636-2638.
    View in: PubMed
    Score: 0.052
  38. Correction to: Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis. J Thromb Thrombolysis. 2019 Jan; 47(1):41.
    View in: PubMed
    Score: 0.051
  39. Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis. J Thromb Thrombolysis. 2019 Jan; 47(1):31-40.
    View in: PubMed
    Score: 0.051
  40. Cardiopulmonary Exercise Testing in Patients Following Massive and Submassive Pulmonary Embolism. J Am Heart Assoc. 2018 03 03; 7(5).
    View in: PubMed
    Score: 0.048
  41. The Role of the Pulmonary Embolism Response Team: How to Build One, Who to Include, Scenarios, Organization, and Algorithms. Tech Vasc Interv Radiol. 2017 Sep; 20(3):216-223.
    View in: PubMed
    Score: 0.046
  42. A Multidisciplinary Pulmonary Embolism Response Team: Initial 30-Month Experience With a Novel Approach to Delivery of Care to Patients With Submassive and Massive Pulmonary Embolism. Chest. 2016 08; 150(2):384-93.
    View in: PubMed
    Score: 0.042
  43. Thrombectomy using suction filtration and veno-venous bypass: single center experience with a novel device. Catheter Cardiovasc Interv. 2015 Aug; 86(2):E81-7.
    View in: PubMed
    Score: 0.040
  44. Proximal versus distal embolic protection for carotid artery stenting: a national cardiovascular data registry analysis. JACC Cardiovasc Interv. 2015 Apr 20; 8(4):609-15.
    View in: PubMed
    Score: 0.039
  45. A comparison of patients diagnosed with pulmonary embolism who are =65 years with patients <65 years. Am J Cardiol. 2015 Mar 01; 115(5):681-6.
    View in: PubMed
    Score: 0.039
  46. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA. 2014 Jun 18; 311(23):2414-21.
    View in: PubMed
    Score: 0.037
  47. The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): creation of a multidisciplinary program to improve care of patients with massive and submassive pulmonary embolism. Hosp Pract (1995). 2014 Feb; 42(1):31-7.
    View in: PubMed
    Score: 0.036
  48. Unprotected carotid artery stenting in modern practice. Catheter Cardiovasc Interv. 2014 Mar 01; 83(4):595-602.
    View in: PubMed
    Score: 0.036
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.